RHYTHM PHARMACEUTICALS ANNOUNCES PRELIMINARY DATA FROM PHASE 2 TRIAL THAT SHOWED RM-718 DEMONSTRATED POSITIVE EFFICACY SIGNAL IN ACQUIRED HYPOTHALAMIC OBESITY

Reuters · 08/04 10:55

Please log in to view news